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Immunization ofBALB/c mice with a single dose of the 
Sabin type 1, type 2 or type 3 poliovirus vaccine strains 
stimulated cross-reactive T helper cell responses 
detected by both in vitro proliferation and interleukin 
(IL)-2/IL-4 production. Although the polyclonal T cell 
responses were cross-reactive, the results also suggest 
that a proportion of the T cells were directed against 
serotype-specific determinants. In contrast, neutraliz- 
ing antibodies, assayed in the serum from the same 
animals, were predominantly serotype-specific and 
only reached significant titres after secondary immuni- 
zation. A comparison of the immunogenicity of 
poliovirus administered subcutaneously in Freund's 
complete adjuvant or intraperitoneally as an alum 
precipitate or without adjuvant, showed that optimum 
responses were obtained by immunization with virus in 
the presence of alum. An examination of the effect of 
heterotypic priming showed that immunization with 
type 2 virus primed for a secondary antibody response 
to each of the three serotypes, whereas priming with 
type 1 or type 3 viruses could only generate a secondary 
antibody response to the homologous virus or to type 2 
virus. 
Introduction 
The ability of poliovirus vaccines to protect the host 
against disease has been attributed directly to the 
generation ofantiviral neutralizing antibodies (Gl zen et 
al., 1969). However, protection against disease is 
possible in the virtual absence of measurable circulating 
neutralizing antibodies, for example where the levels 
have waned after the last vaccination (Bottiger, 1973), or 
after a single immunization with the inactivated polio- 
virus vaccine. It has been suggested that immunological 
memory could account for this protection (Salk et al., 
1984). Although the nature of immunological memory to 
poliovirus has not been fully investigated, it seems 
probable that the role of circulating neutralizing anti- 
body would be the immediate prevention of infection, 
whereas immunological memory would provide durable 
immunity in the long term. 
Although the antigenic structure of poliovirus is well 
characterized, with at least four neutralizing epitopes 
identified (Minor, 1990) and located on the three- 
dimensional structure of the virus particle (Hogle et al., 
1985; Filman et al., 1989; Page et al., 1988), the role ofT 
cells in the immune response to poliovirus has not been 
established. T cells are known to have important 
functions in immune protection against viral diseases. 
Major histocompatibility complex (MHC) class II- 
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restricted T helper (Th) cells proliferate after stimulation 
with antigen, secrete cytokines, such as interleukin 
(IL)-2, IL-4 and ~-interferon, and activate B cells to 
produce antibody (Reinherz & Schlossman, 1981; 
Schwartz, 1985; Paul, 1989); MHC class I cytotoxic 
T cells have the capacity to lyse virus-infected cells, 
thus directly inhibiting virus replication (Zinkernagel & 
Doherty, 1979). T cell responses have been demonstrated 
with a range of viruses including human immuno- 
deficiency virus, measles virus, respiratory syncytial 
virus and influenza virus (Mills, 1989), hepatitis B 
virus (HBV) (Milich & McLachlan, 1988), coxsackie B4 
and mumps viruses (Bruserud & Thorsby, 1985), foot- 
and-mouth disease virus (Collen et al., 1989) and 
Theiler's murine encephalomyelitis v rus (Welsh et al., 
1989). 
In this report we examined the specificity of T cell 
proliferative and antibody responses following primary 
and secondary immunization of mice with poliovirus. 
We show that neutralizing antibody responses which 
only reached significant titres after secondary immuniza- 
tion were mainly serotype-specific, whereas T cell 
proliferative responses were cross-reactive. Further- 
more, after secondary immunization with one virus 
serotype, antibody responses increased significantly in 
mice primed with another virus serotype, which suggests 
that cross-reactive Th cells may play a role in heterotypic 
priming with poliovirus. 
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Methods 
Virus preparations. Attenuated live poliovirus vaccine strains Sabin 
type 1, 2 and 3 were used throughout. Viruses were propagated in Hep- 
2c cells and purified concentrates obtained as described by M nor 
(1985). Briefly, infected tissue culture fluid was clarified by low speed 
centrifugation (3000 g), precipitated with 0.4g/ml ammonium sulphate 
and purified through a 15 to 45% sucrose gradient. Fractions 
containing virus were pooled, centrifuged at 30000 g for 4 h and pellets 
were resuspended in phosphate-buffered saline. Virus infectivity was 
determined by plaque assay as described below and the concentrates 
were stored as aliquots at -70°C. Protein concentrations were 
estimated using the Bio-Rad Protein Assay Kit I. 
Microneutralization assay. Dilutions of sera in MEM supplemented 
with 1% foetal calf serum (FCS), 1.4 ~tg/ml penicillin, 1 Ixg/ml 
streptomycin and 10/ag/ml Fungizone were incubated with 100 
TCIDso of virus in 96-well microtitre plates (Falcon Plastics) for 3 h at 
35 °C. Hep-2c ells in suspension were then added at approximately 
1 x 104 cells per well and the plates were re-incubated for 3 days at 
35 °C in a humidified incubator with 5 % CO2. Each test was performed 
in quadruplicate and the results expressed as the reciprocal log2 or log10 
of the final dilution f serum that totally inhibited the viral c.p.e. 
Results are expressed a  geometric mean titres (GMT) of duplicate 
titrations. 
In the context of this study, a primary response has been defined as
an antibody titre detected 14 days after the first immunization, whereas 
a secondary response is an increase in the antibody titre of fourfold or 
greater than the primary response measured 14 days after the booster 
immunization. 
Plaque assay. Serial loglo dilutions of virus were allowed to adsorb 
on Hep-2c cell monolayers in FB-6 plates (Flow Laboratories) for 1 h at 
room temperature with occasional shaking. Excess fluid was removed 
and wells were covered with an agarose overlay containing MEM 
supplemented with serum and antibiotics. After 3 clays incubation at 
35 °C in a humidified incubator with 5 % CO2, the overlay was flicked 
off and the cell monolayer stained with 1% naphthalene black to 
visualize plaques. Results were expressed as p.f.u./ml. 
Mouse immunizations. Female BALB/c mice (between 8 and10 weeks 
old), maintained as an inbred colony at NIBSC, were used for all 
experiments. Virus emulsified in Freund's complete adjuvant (CFA) 
was inoculated subcutaneously (s.c.) at the base of the neck, whereas 
virus without adjuvant or virus precipitated with alum as adminis- 
tered intraperitoneally (i.p.). Each mouse received approximately 108 
p.f.u, purified virus (equivalent to approximately 1 /.tg of protein). 
Serum samples prepared from peripheral blood were collected 14 days 
after either primary or secondary immunization, immediately before 
removal of spleens, which were used in T cell assays. 
Proliferation assay. Spleens from immunized BALB/c mice were 
individually homogenized and suspended in RPMI 1640 supplemented 
with either 8 % heat-inactivated FCS or 2 % normal mouse serum. Cells 
(4 x 105/well) were cultured in 96-well flat-bottomed microtitre plates 
in the presence of either poliovirus (at concentrations between 4 x 106 
and 1 x 109 p.f.u./ml) or medium alone. Cultures were incubated for 3 
to 4 days and pulse-labelled with 0-5p.Ci [3H]thymidine for the final 4 to 
6 hours. [3H]thymidine incorporation was measured by liquid 
scintillation counting after harvesting cultures on to filter paper. 
Results were expressed as me n c.p.m, in triplicate cultures, or as A 
c.p.m, after subtracting the background c.p.m, measured in the 
absence of antigen. 
Cytokine assay. Cytokine release was assessed by testing the ability of 
supernatants to support the proliferation of the IL-2/IL-4-dependent 
cell line CTLL-2 (Gillis etal., 1978). The CTLL-2 cell line responded to 
recombinant IL-2 and IL-4, but these responses were abolished 
by monoclonal antibodies to the IL-2 receptor or IL-4 respectively. 
Supernatant (50 lal), removed after 24 h of culture, was added to 50 lal (1 
x 104) CTLL-2 ceils that had been washed free of residual IL-2 for 2 h 
before the assay. CTLL-2 proliferation was determined after 24 h by 
[3H]thymidine incorporation. Results were expressed as the mean 
c.p.m, for triplicate assays after subtraction of background controls. 
Results 
Specificity of neutralizing antibody responses to poliovirus 
after primary and secondary immunization 
Sera from mice immunized with one or two doses of type 
1 or type 3 virus in alum, CFA or no adjuvant, were 
tested for neutral izing activity against each of the three 
serotypes. Neutral ization titres of pooled sera from 
groups of five mice are shown in Fig. 1. 
Pr imary immunizat ion of mice with type 1 virus 
generated serotype-specific neutral izing antibodies with 
titres between 1 : 160 and 1 : 640 obtained on day 14 post- 
immunizat ion.  The max imum titre of 1 : 640 was detected 
in mice immunized i.p. with type 1 virus in the presence 
of alum (Fig. l c). A booster immunizat ion with 
homotypic virus produced a significant increase in 
secondary antibody titre, especially in the presence of 
alum (1 : 10240). Mice immunized with type 1 virus did 
not generate cross-neutralizing antibodies to type 3 virus 
(Fig. 1), even after four immunizat ions (data not shown). 
However, low levels of cross-reactive ant ibody were 
detected against type 2 virus (Fig. l a and c). The 
addition of adjuvants did not augment neutral izing 
antibody titres to type 3 virus over that obtained by 
immunizat ion with virus alone. Pr imary antibody titres 
to type 3 virus were consistently lower than those 
generated by type 1 virus. However, secondary immuni-  
zation with omotypic virus produced a significant boost 
in antibody titre (1:160), indicating that mice were 
successfully primed after the first immunizat ion.  Addi- 
tionally, mice immunized with type 3 virus did not 
generate cross-neutralizing antibodies to type 1 virus, 
even after four immunizat ions (data not shown). 
Specificity of proliferative T cell responses to p liovirus 
after primary and secondary immunization 
The ability of polioviruses to stimulate virus-specific T 
cell responses was initially studied by immuniz ing mice 
with either one or two doses of type 1 and type 3 viruses, 
in the presence or absence of adjuvants. Low levels of 
cross-reactive proliferative responses were detected in 
pooled spleen cells of mice immunized with either 
serotype (Fig. 2). The use of CFA (s.c.) or alum (i.p.) did 
not significantly enhance the proliferative responses 
after pr imary immunizat ion,  indeed, a slight reduction 
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Fig. 1. Serotype specificity of neutralizing antibody responses to 
poliovirus. Antisera were tested 14 days after primary (filled) or 
secondary (shaded) immunization of mice with type 1 (a to c) or type 3 
(d to f)  poliovirus, without adjuvant (a and d), with CFA (b and e) or 
with alum (c and f). Each bar represents the titre of an equal volume 
pool of five sera nd is expressed as the reciprocal of the log10 dilution 
which neutralized type 1 (1), type 2 (2) and type 3 (3) viruses. 
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Fig. 2. Specificity of proliferative T cell responses following poliovirus 
immunization. Pools f spleen cells from groups of five mice were 
isolated 14 days after primary (filled) and secondary (shaded) 
immunization with type 1 (a to c) or type 3 (d to f)  viruses, in the 
absence of adjuvant (a and d), with CFA (b and e) or with alum (c and 
f). Proliferation was measured 3 days after stimulation with 5 × 10 s 
p.f.u./ml of type 1 (1), type 2 (2) or type 3 (3) polioviruses. Results are
expressed as A c.p.m, after subtraction of background responses to 
medium alone, which ranged from 5000 to 10000 c.p.m. 
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Fig. 3. IL2/IL4 secretion by immune spleen cells following stimulation 
by poliovirus types 1, 2 and 3. Primary and secondary immunizations 
and measurement of proliferation are described in the legend to Fig. 2. 
was detected in mice immunized s.c. with virus 
emulsified in CFA (Fig. 2b and e). After secondary 
immunizat ion with homotypic virus, the in vitro T cell 
responses increased, especially in spleen cells obtained 
from mice immunized with virus in the presence of 
adjuvant (Fig. 2, 3). For example, spleen cells from mice 
immunized with type 3 virus in alum (Fig. 2 f )  showed 
higher levels of proliferation than in the absence of 
adjuvant (Fig 2d). However,  in contrast with neutraliz- 
ing antibody production, this effect was not seen with 
type 1 virus (Fig. 2a to c). 
A cytokine release assay, which measures the amount 
of IL-2/IL-4 released into the supernatant fluid by 
antigen-stimulated T cells (Fig 3), largely confirmed the 
results shown in Fig. 2 and showed that proliferative 
activity of spleen cells from pol iovirus- immunized mice 
was probably a function of the Th cell population. 
The results of the T cell responses taken together with 
neutralization data Suggested that i,p. immunizat ion 
with poliovirus adsorbed with alum gave the most 
satisfactory immune responses. Therefore all subsequent 
immunizat ion studies were performed using alum as 
adjuvant. In order to study T cell responses in more 
detail, we examined the responses of mice pr imed with 
type 1, 2 and 3 viruses. In these proliferation experi- 
ments, normal mouse serum was substituted for FCS in 
order to reduce the high background levels shown in Fig. 
2. The data shown in Fig. 4 clearly demonstrate that 
proliferation of spleen cells from individual mice was 
antigen dose-dependent and cross-reactive between type 
1 and type 3 viruses, following pr imary immunizat ion 
with either virus serotype. In addition, spleen cells 
derived from individual mice immunized with one dose 
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Fig. 4. Antigen dose-dependent proliferation of immune spleen cells in 
vitro. Proliferative response of spleen cells from mice immunized with 
either type 1 (a and b) or type 3 (c and d) viruses were tested against a 
range of concentrations of type 1 (a and c) or type 3 (b and d) 
polioviruses. Each curve represents he proliferative response of spleen 
cells obtained from a single mouse. 
(Fig. 5 a, c and e) or two doses (Fig. 5 b, d and f )  of type 2 
virus showed that proliferation was cross-reactive and 
dose-dependent but not significantly increased after 
secondary immunization with homologous virus. 
Heterotypic priming and its effect on neutralizing 
antibody production and T cell responses 
As shown in Fig. 1, secondary immunization with 
homotypic virus produced a boost in neutralizing 
antibody titres against both type 1 and type 3 viruses 
which were serotype-specific and cross-reacted weakly 
only with type 2 virus. However, as spleen cells from the 
same groups of mice showed broadly cross-reactive T cell 
proliferative activity, it is possible that such cross- 
reactive T cells may be capable of establishing hetero- 
typic memory in vivo. We therefore xamined the effect 
of heterotypic priming on antibody and T cell responses. 
The results hown in Fig. 6 demonstrate hat the cross- 
reactive component ofthe T cell response against type 1 
or type 3 viruses observed after primary immunization 
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Fig. 5. Antigen-dependent proliferation of spleen cells in vitro in 
response to type 1 (a and b), 2 (c and d) or 3 (e and f )  viruses after 
primary (a, c and e) and secondary (b, d and f )  immunization with 
type 2 virus in alum. Each curve represents he proliferative response 
of an individual mouse. 
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Fig. 6. Specificity of T cell proliferative responses after heterotypic 
priming. Mice primed with type 2 virus were boosted with either type 1, 
type 2 or type 3 viruses. Proliferation was measured 3 days after 
stimulation with 108 p.f.u, of type 1, 2 or 3 viruses. Each bar represents 
the mean c.p.m, of groups of three mice. Results are xpressed as A 
c.p.m, after subtraction of background responses to medium alone, 
which ranged from 500 to 2000 c.p.m. [--1, Type 1 virus; ~], type 2 virus; 
II, type 3 virus. 
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Table 1. Effect of heterologous priming on neutralizing 
antibody specificity 
Neutralizing antibody titre 
after second immunization 
First Antibody Second 
immunization titre* immunization Type 1 Type 2 Type 3 
- <t  Type 1 56 < < 
< Type 2 < 538 < 
< Type 3 < < 47 
Type 1 80 Type 1 1810 < < 
Type 1 16 Type 2 20 1076 < 
Type 1 14 Type 3 28 < 40 
Type 2 226 Type 1 226 1076 < 
Type 2 269 Type 2 < 4063 < 
Type 2 226 Type 3 < 403 201 
Type 3 < Type 1 67 < < 
Type 3 < Type 2 < 1522 < 
Type 3 < Type 3 < < 269 
* Neutralizing antibody titres tested 30 days post-primary immuni- 
zation, immediately before second immunization. 
t Indicates GMT below 1 : 10 dilution. 
with type 2virus is boosted considerably after s condary 
immunization with the heterologous virus. Generally, 
the highest proliferative response was obtained against 
the serotype used for the second immunization, although 
the response to type 1 virus was consistently ower than 
that to type 2 or 3 viruses (Fig. 6). Although these results 
clearly demonstrate cross-reactivity between the three 
serotypes, they also suggest that a component of the T 
cell response to the type 2 virus is serotype-specific. 
As previously observed (Fig. 1), significant increases 
in serotype-specific neutralizing antibody responses 
were generated in mice primed with type 1 or type 3 
viruses after boosting with homotypic virus (Table 1). 
However, neutralizing antibody titres were also aug- 
mented in mice primed with type 2 virus and boosted 
with either homotypic or heterotypic virus (Table 1). For 
example, mice primed with type 2 virus generated anti- 
type 2 virus titres of 1:538 which increased to 1:4063 
after boosting with type 2 virus. Furthermore, mice 
primed with type 2 virus followed by boosting with type 1
virus generated titres of 1:226 and 1 : 1076 against ype 1 
and type 2 viruses respectively, whereas boosting with 
type 3 virus generated titres of 1:403 and 1:201 against 
type 2 and type 3 viruses respectively. Heterotypic 
priming was also observed in mice primed with either 
type 1 or type 3 viruses and boosted with type 2 (Table 1). 
For example, secondary antibody titres against ype 2 
virus of 1 : 1522 and 1 : 1076 were detected in mice primed 
with type 3and type 1 virus respectively, although these 
levels show only a two- to threefold increase in primary 
antibody titres. In contrast, heterotypic priming between 
type 1 and type 3 viruses was not observed (Table 1). 
Table 2. Summary of T and B cell responses to poliovirus 
Response 
T cell 
Recognition 
of poliovirus 
in vitro 
Immunization with poliovirus 
Type 1 Type 2 Type 3 
Neutralizing 
antibody 
Type 1 + + * + + 
Type 2 + + + + + + 
Type 3 + + + + + 
Type 1 + + + - - 
Type 2 +/ -  + + + - 
Type 3 - - + + 
* The results represent data from at least five independent 
experiments and are presented as positive (+),  negative ( - )  or 
inconclusive (+/ - ) .  
Discussion 
In a study of poliovirus immunity in mice, we have 
identified immunization protocols capable of generating 
consistent humoral and cell-mediated immune responses 
and shown that a cross-reactive T cell response can be 
detected after a single immunization. In contrast, 
neutralizing antibodies assayed in serum from the same 
animals were mainly serotype-specific (summarized in 
Table 2). Furthermore, immunization with type 2 
poliovirus was found to prime for a secondary antibody 
response to each of the three serotypes, whereas priming 
with type 1 or type 3 virus could only generate a 
secondary response to the homologous virus or to type 2 
virus. Although there is evidence for some cross- 
reactivity at the antibody level between type I and type 2 
viruses, our results raise the possibility that heterotypic 
memory at the Th cell level may play a role in the 
stimulation of cross-reactive immune response to polio- 
virus and thus in immune protection against 
poliomyelitis. 
The cooperation of Th cells with B cells to generate 
neutralizing antibody is a well established phenomenon. 
In a study by UytdeHaag et al. (1985), the production of 
neutralizing antibody to poliovirus in vitro could be 
generated by restimulation of cultured human lympho- 
cytes with antigen, but only in the presence of Th cells. 
Our studies show that in mice immunized with polio- 
virus, neutralizing antibody responses were g nerated 
concomitantly with cross-reactive Th cell responses. 
Cross-reactive T cell proliferative responses were also 
reported by Wang et al. (1989) after immunization of 
mice with u.v.-inactivated wild-type poliovirus strains. 
However, in their studies, lymph node cells from mice 
immunized with type 3 (Leon) virus did not cross- 
proliferate with type 1 (LS-a) virus, which may suggest 
greater heterogeneity between wild-type polioviruses 
than between the Sabin strains used in our study. 
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Although we have demonstrated intertypic ross-reacti- 
vity following immunization with each of the three virus 
serotypes, there is also evidence that a component of the 
T cell response was serotype-specific. In general, the 
strongest T cell responses were demonstrated against he 
immunizing subtype (Table 2). Furthermore, following 
heterotypic priming we detected an amplification in the 
cross-reactive r sponse to the virus serotype used for 
secondary immunization of mice primed with virus of 
another serotype. 
It has been shown that Th cells specific for the internal 
nucleoprotein or matrix protein of influenza virus and 
the nucleoprotein of HBV, can provide help to B cell 
production of neutralizing antibody against the more 
variable influenza virus haemagglutinin and HBV 
surface proteins respectively (Scherle & Gerhard, 1986; 
Milich & McLachlan, 1988). The production of anti- 
poliovirus neutralizing antibodies, against he generally 
variable xposed loop regions of the capsid proteins, may 
thus be mediated through helper functions provided by 
Th cells which recognize regions conserved between the 
three virus serotypes. Our data suggest that immuniza- 
tion with type 2 virus could prime for a secondary 
response to all three virus serotypes. However, immuni- 
zation with type 1 or type 3 viruses did not prime for a 
significant increase in antibody levels after secondary 
immunization with virus of a different serotype. Al- 
though the neutralizing antibody response to type 2 virus 
has not been thoroughly investigated, the isolation of 
cross-reactive monoclonal antibodies which neutralize 
both type 1 and type 2 viruses (M. Ferguson, personal 
communication; Uhlig et al., 1990) demonstrates the 
existence of type-common epitopes hared by these two 
serotypes. Our results on the cell-mediated immune 
response to poliovirus suggest hat Th cells directed 
against sites conserved between type 2 and type 1 and 
between type 2 and type 3 viruses may also play a role in 
heterotypic immunity to poliovirus infections. 
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